{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:32:02Z","timestamp":1791613922077,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2018R1A5A2025964"],"award-info":[{"award-number":["NRF-2018R1A5A2025964"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2020-0230"],"award-info":[{"award-number":["04-2020-0230"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2020-0230"],"award-info":[{"award-number":["04-2020-0230"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2020-0230"],"award-info":[{"award-number":["04-2020-0230"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2020-0230"],"award-info":[{"award-number":["04-2020-0230"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2020-0230"],"award-info":[{"award-number":["04-2020-0230"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","award":["04-2020-0230"],"award-info":[{"award-number":["04-2020-0230"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003664","name":"Korea Forest Service","doi-asserted-by":"publisher","award":["2020195A00-2122-BA01"],"award-info":[{"award-number":["2020195A00-2122-BA01"]}],"id":[{"id":"10.13039\/501100003664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003664","name":"Korea Forest Service","doi-asserted-by":"publisher","award":["2020195A00-2122-BA01"],"award-info":[{"award-number":["2020195A00-2122-BA01"]}],"id":[{"id":"10.13039\/501100003664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003664","name":"Korea Forest Service","doi-asserted-by":"publisher","award":["2020195A00-2122-BA01"],"award-info":[{"award-number":["2020195A00-2122-BA01"]}],"id":[{"id":"10.13039\/501100003664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003664","name":"Korea Forest Service","doi-asserted-by":"publisher","award":["2020195A00-2122-BA01"],"award-info":[{"award-number":["2020195A00-2122-BA01"]}],"id":[{"id":"10.13039\/501100003664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003664","name":"Korea Forest Service","doi-asserted-by":"publisher","award":["2020195A00-2122-BA01"],"award-info":[{"award-number":["2020195A00-2122-BA01"]}],"id":[{"id":"10.13039\/501100003664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003664","name":"Korea Forest Service","doi-asserted-by":"publisher","award":["2020195A00-2122-BA01"],"award-info":[{"award-number":["2020195A00-2122-BA01"]}],"id":[{"id":"10.13039\/501100003664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ01589402"],"award-info":[{"award-number":["PJ01589402"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ01589402"],"award-info":[{"award-number":["PJ01589402"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ01589402"],"award-info":[{"award-number":["PJ01589402"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ01589402"],"award-info":[{"award-number":["PJ01589402"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ01589402"],"award-info":[{"award-number":["PJ01589402"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003627","name":"Rural Development Administration","doi-asserted-by":"publisher","award":["PJ01589402"],"award-info":[{"award-number":["PJ01589402"]}],"id":[{"id":"10.13039\/501100003627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor acidosis, a common phenomenon in solid cancers such as breast cancer, is caused by the abnormal metabolism of cancer cells. The low pH affects cells surrounding the cancer, and tumor acidosis has been shown to inhibit the activity of immune cells. Despite many previous studies, the immune surveillance mechanisms are not fully understood. We found that the expression of PD-L1 was significantly increased under conditions of extracellular acidosis in MDA-MB-231 cells. We also confirmed that the increased expression of PD-L1 mediated by extracellular acidosis was decreased when the pH was raised to the normal range. Gene set enrichment analysis (GSEA) of public breast cancer patient databases showed that PD-L1 expression was also highly correlated with IL-6\/JAK\/STAT3 signaling. Surprisingly, the expression of both phospho-tyrosine STAT3 and PD-L1 was significantly increased under conditions of extracellular acidosis, and inhibition of STAT3 did not increase the expression of PD-L1 even under acidic conditions in MDA-MB-231 cells. Based on these results, we suggest that the expression of PD-L1 is increased by tumor acidosis via activation of STAT3 in MDA-MB-231 cells.<\/jats:p>","DOI":"10.1186\/s12885-022-09956-9","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T05:04:10Z","timestamp":1659589450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The acidic tumor microenvironment enhances PD-L1 expression via activation of STAT3 in MDA-MB-231 breast cancer cells"],"prefix":"10.1186","volume":"22","author":[{"given":"Yong-Jin","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Bi","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae Jin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kum Hee","family":"Noh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangsik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Mu","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Rae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Kyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"issue":"3","key":"9956_CR1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg effect: How does it benefit cancer cells? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"9956_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-019-0259-8","volume":"20","author":"LB Ivashkiv","year":"2020","unstructured":"Ivashkiv LB. The hypoxia\u2013lactate axis tempers inflammation. Nat Rev Immunol. 2020;20(2):85\u20136.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"9956_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Tumour acidosis: From the passenger to the driver's seat. Nat Rev Cancer. 2017;17(10):577\u201393.","journal-title":"Nat Rev Cancer"},{"key":"9956_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","volume":"9","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO, Garc\u00eda-Carranc\u00e1 A, Manzo-Merino J. Lactate in the regulation of tumor microenvironment and therapeutic approaches. Front Oncol. 2019;9:1143.","journal-title":"Front Oncol"},{"key":"9956_CR5","doi-asserted-by":"crossref","unstructured":"Lei Q, Wang D, Sun K, Wang L, Zhang Y. Resistance mechanisms of anti-PD1\/PDL1 therapy in solid tumors. Front Cell De Biol. 2020;8:672.","DOI":"10.3389\/fcell.2020.00672"},{"issue":"7","key":"9956_CR6","first-page":"747","volume":"8","author":"J Eno","year":"2017","unstructured":"Eno J. Immunotherapy through the years. J Adv Pract Oncol. 2017;8(7):747.","journal-title":"J Adv Pract Oncol"},{"issue":"11","key":"9956_CR7","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jtho.2016.06.006","volume":"11","author":"K Takada","year":"2016","unstructured":"Takada K, Okamoto T, Shoji F, Shimokawa M, Akamine T, Takamori S, et al. Clinical significance of PD-L1 protein expression in surgically resected primary lung adenocarcinoma. J Thorac Oncol. 2016;11(11):1879\u201390.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"9956_CR8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/cells10020229","volume":"10","author":"SK Parvathareddy","year":"2021","unstructured":"Parvathareddy SK, Siraj AK, Ahmed SO, Ghazwani LO, Aldughaither SM, Al-Dayel F, et al. PD-L1 protein expression in middle eastern breast cancer predicts favorable outcome in triple-negative breast cancer. Cells. 2021;10(2):229.","journal-title":"Cells"},{"issue":"2","key":"9956_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","volume":"19","author":"J Huynh","year":"2019","unstructured":"Huynh J, Chand A, Gough D, Ernst M. Therapeutically exploiting STAT3 activity in cancer\u2014Using tissue repair as a road map. Nat Rev Cancer. 2019;19(2):82\u201396.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"9956_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-018-1018-6","volume":"38","author":"J-J Qin","year":"2019","unstructured":"Qin J-J, Yan L, Zhang J, Zhang W-D. STAT3 as a potential therapeutic target in triple negative breast cancer: A systematic review. J Exp Clin Cancer Res. 2019;38(1):1\u201316.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"9956_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in cancer immunotherapy. Mol Cancer. 2020;19(1):1\u201319.","journal-title":"Mol Cancer"},{"issue":"13","key":"9956_CR12","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1158\/0008-5472.CAN-16-2938","volume":"77","author":"P Seth","year":"2017","unstructured":"Seth P, Csizmadia E, Hedblom A, Vuerich M, Xie H, Li M, et al. Deletion of lactate dehydrogenase-a in myeloid cells triggers antitumor immunity. Cancer Res. 2017;77(13):3632\u201343.","journal-title":"Cancer Res"},{"issue":"4","key":"9956_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cancers11040450","volume":"11","author":"S Daneshmandi","year":"2019","unstructured":"Daneshmandi S, Wegiel B, Seth P. Blockade of lactate dehydrogenase-a (LDH-A) improves efficacy of anti-programmed cell death-1 (PD-1) therapy in melanoma. Cancers. 2019;11(4):450.","journal-title":"Cancers"},{"issue":"6","key":"9956_CR14","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","volume":"76","author":"S Pilon-Thomas","year":"2016","unstructured":"Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, Russell S, Weber AM, Luddy K, et al. Neutralization of tumor acidity improves antitumor responses to immunotherapy. Cancer Res. 2016;76(6):1381\u201390.","journal-title":"Cancer Res"},{"issue":"1","key":"9956_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-017-0311-9","volume":"6","author":"J Gong","year":"2018","unstructured":"Gong J, Chehrazi-Raffle A, Reddi S, Salgia R. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations. J Immunother Cancer. 2018;6(1):1\u201318.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"9956_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/d41573-019-00182-w","volume":"19","author":"JX Yu","year":"2020","unstructured":"Yu JX, Hodge JP, Oliva C, Neftelinov ST, Hubbard-Lucey VM, Tang J. Trends in clinical development for PD-1\/PD-L1 inhibitors. Nat Rev Drug Discov. 2020;19(3):163\u20134.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9956_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-019-0779-5","volume":"12","author":"A Akinleye","year":"2019","unstructured":"Akinleye A, Rasool Z. Immune checkpoint inhibitors of PD-L1 as cancer therapeutics. J Hematol Oncol. 2019;12(1):1\u201313.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"9956_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/cells9040989","volume":"9","author":"Y-J Kwon","year":"2020","unstructured":"Kwon Y-J, Seo E-B, Kwon S-H, Lee S-H, Kim S-K, Park SK, et al. Extracellular acidosis promotes metastatic potency via decrease of the BMAL1 circadian clock gene in breast cancer. Cells. 2020;9(4):989.","journal-title":"Cells"},{"key":"9956_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2019.00004","volume":"7","author":"W Al Tameemi","year":"2019","unstructured":"Al Tameemi W, Dale TP, Al-Jumaily RMK, Forsyth NR. Hypoxia-modified cancer cell metabolism. Front Cell Dev Biol. 2019;7:4.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"9956_CR20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3390\/cancers11101479","volume":"11","author":"I Zerdes","year":"2019","unstructured":"Zerdes I, Wallerius M, Sifakis EG, Wallmann T, Betts S, Bartish M, et al. STAT3 activity promotes programmed-death ligand 1 expression and suppresses immune responses in breast cancer. Cancers. 2019;11(10):1479.","journal-title":"Cancers"},{"key":"9956_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmet.2019.07.006","volume":"33","author":"VL Payen","year":"2020","unstructured":"Payen VL, Mina E, Van H\u00e9e VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48\u201366.","journal-title":"Mol Metab"},{"issue":"1","key":"9956_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"E-Y Kim","year":"2019","unstructured":"Kim E-Y, Chung T-W, Han CW, Park SY, Park KH, Jang SB, et al. A novel lactate dehydrogenase inhibitor, 1-(phenylseleno)-4-(trifluoromethyl) benzene, suppresses tumor growth through apoptotic cell death. Sci Rep. 2019;9(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"12","key":"9956_CR23","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-18-0107","volume":"17","author":"T Todenh\u00f6fer","year":"2018","unstructured":"Todenh\u00f6fer T, Seiler R, Stewart C, Moskalev I, Gao J, Ladhar S, et al. Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer. Mol Cancer Ther. 2018;17(12):2746\u201355.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"9956_CR24","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-07-5575","volume":"69","author":"IF Robey","year":"2009","unstructured":"Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, et al. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 2009;69(6):2260\u20138.","journal-title":"Cancer Res"},{"key":"9956_CR25","doi-asserted-by":"crossref","unstructured":"Pramod Kumar EK, Um W, Park JH. Recent developments in pathological pH-responsive polymeric nanobiosensors for cancer theranostics. Front Bioeng Biotechnol. 2020:8;601586.","DOI":"10.3389\/fbioe.2020.601586"},{"key":"9956_CR26","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhou X, Wang W, Wu Y, Qian Z, Peng Q. Sodium bicarbonate, an inorganic salt and a potential active agent for cancer therapy. Chin Chem Lett. 2021;32(12):3687\u201395.","DOI":"10.1016\/j.cclet.2021.06.032"},{"issue":"7","key":"9956_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/sj.bjc.6690455","volume":"80","author":"N Raghunand","year":"1999","unstructured":"Raghunand N, He X, Van Sluis R, Mahoney B, Baggett B, Taylor C, et al. Enhancement of chemotherapy by manipulation of tumour pH. Br J Cancer. 1999;80(7):1005\u201311.","journal-title":"Br J Cancer"},{"issue":"52","key":"9956_CR28","doi-asserted-by":"publisher","first-page":"86026","DOI":"10.18632\/oncotarget.13323","volume":"7","author":"S Faes","year":"2016","unstructured":"Faes S, Uldry E, Planche A, Santoro T, Pythoud C, Demartines N, et al. Acidic pH reduces VEGF-mediated endothelial cell responses by downregulation of VEGFR-2; relevance for anti-angiogenic therapies. Oncotarget. 2016;7(52):86026.","journal-title":"Oncotarget"},{"issue":"1","key":"9956_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-016-0562-y","volume":"15","author":"S Faes","year":"2016","unstructured":"Faes S, Duval AP, Planche A, Uldry E, Santoro T, Pythoud C, et al. Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors. Mol Cancer. 2016;15(1):1\u201311.","journal-title":"Mol Cancer"},{"issue":"2","key":"9956_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-021-00574-0","volume":"23","author":"JD Twomey","year":"2021","unstructured":"Twomey JD, Zhang B. Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics. AAPS J. 2021;23(2):1\u201311.","journal-title":"AAPS J"},{"issue":"12","key":"9956_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd.2018.210","volume":"17","author":"J Tang","year":"2018","unstructured":"Tang J, Yu JX, Hubbard-Lucey VM, Neftelinov ST, Hodge JP, Lin Y. Trial watch: The clinical trial landscape for PD1\/PDL1 immune checkpoint inhibitors. Nat Rev Drug Discov. 2018;17(12):854\u20136.","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"9956_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","volume":"6","author":"Q Duan","year":"2020","unstructured":"Duan Q, Zhang H, Zheng J, Zhang L. Turning cold into hot: Firing up the tumor microenvironment. Trends Cancer. 2020;6(7):605\u201318.","journal-title":"Trends Cancer"},{"issue":"6","key":"9956_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1248\/bpb.b21-00076","volume":"44","author":"H Ando","year":"2021","unstructured":"Ando H, Emam SE, Kawaguchi Y, Shimizu T, Ishima Y, Eshima K, et al. Increasing tumor extracellular pH by an Oral alkalinizing agent improves antitumor responses of anti-PD-1 antibody: Implication of relationships between serum bicarbonate concentrations, urinary pH, and therapeutic outcomes. Biol Pharm Bull. 2021;44(6):844\u201352.","journal-title":"Biol Pharm Bull"},{"key":"9956_CR34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jconrel.2019.10.041","volume":"315","author":"J H-s","year":"2019","unstructured":"H-s J, D-s C. Ko M, Kim D, Lee D-h, Lee S, Lee AY, Kang SG, Kim SH, Jung Y: Extracellular pH modulating injectable gel for enhancing immune checkpoint inhibitor therapy. J Control Release. 2019;315:65\u201375.","journal-title":"J Control Release"},{"issue":"1","key":"9956_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9752","volume":"6","author":"M Damaghi","year":"2015","unstructured":"Damaghi M, Tafreshi NK, Lloyd MC, Sprung R, Estrella V, Wojtkowiak JW, et al. Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane. Nat Commun. 2015;6(1):1\u201313.","journal-title":"Nat Commun"},{"issue":"4","key":"9956_CR36","first-page":"4095","volume":"16","author":"AJ West","year":"2018","unstructured":"West AJ, Tsui V, Stylli SS, Nguyen H, Morokoff AP, Kaye AH, et al. The role of interleukin-6-STAT3 signalling in glioblastoma. Oncol Lett. 2018;16(4):4095\u2013104.","journal-title":"Oncol Lett"},{"issue":"12","key":"9956_CR37","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","volume":"27","author":"R Morris","year":"2018","unstructured":"Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK\/STAT pathway. Protein Sci. 2018;27(12):1984\u20132009.","journal-title":"Protein Sci"},{"issue":"1","key":"9956_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-020-0527-z","volume":"18","author":"J-h Ma","year":"2020","unstructured":"Ma J-h, Qin L, Li X. Role of STAT3 signaling pathway in breast cancer. Cell Commun Signal. 2020;18(1):1\u201313.","journal-title":"Cell Commun Signal"},{"issue":"7","key":"9956_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5483\/BMBRep.2019.52.7.152","volume":"52","author":"H Lee","year":"2019","unstructured":"Lee H, Jeong AJ, Ye S-K. Highlighted STAT3 as a potential drug target for cancer therapy. BMB Rep. 2019;52(7):415.","journal-title":"BMB Rep"},{"issue":"22","key":"9956_CR40","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1158\/1078-0432.CCR-20-1803","volume":"26","author":"A Kawazoe","year":"2020","unstructured":"Kawazoe A, Kuboki Y, Shinozaki E, Hara H, Nishina T, Komatsu Y, et al. Multicenter phase I\/II trial of napabucasin and pembrolizumab in patients with metastatic colorectal cancer (EPOC1503\/SCOOP trial). Clin Cancer Res. 2020;26(22):5887\u201394.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9956_CR41","doi-asserted-by":"publisher","first-page":"e0228302","DOI":"10.1371\/journal.pone.0228302","volume":"15","author":"L Liu","year":"2020","unstructured":"Liu L, Hou J, Xu Y, Qin L, Liu W, Zhang H, et al. PD-L1 upregulation by IFN-\u03b1\/\u03b3-mediated Stat1 suppresses anti-HBV T cell response. Plos One. 2020;15(7):e0228302.","journal-title":"Plos One"},{"issue":"4","key":"9956_CR42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.17480\/psk.2021.65.4.313","volume":"65","author":"MR Alam","year":"2021","unstructured":"Alam MR, Kim J-I, Lee C-H, Park S-S, Baek M-C. Characterization of immune checkpoint inhibition efficacy through inhibition of exosome secretion by calcium channel blockers in melanoma. Yakhak Hoeji. 2021;65(4):313\u201320.","journal-title":"Yakhak Hoeji"},{"issue":"1","key":"9956_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"JW Moon","year":"2017","unstructured":"Moon JW, Kong S-K, Kim BS, Kim HJ, Lim H, Noh K, et al. IFN\u03b3 induces PD-L1 overexpression by JAK2\/STAT1\/IRF-1 signaling in EBV-positive gastric carcinoma. Sci Rep. 2017;7(1):1\u201313.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09956-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09956-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09956-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T10:02:43Z","timestamp":1659866563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09956-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9956"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09956-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the SNUH Institutional Review Board (IRB; IRB No. 1904\u2013141-1029). This study complied with the Declaration of Helsinki and ICH-GCP (International Conference on Harmonization-Good Clinical Practice), and was performed according to the ICH-GCP guild lines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"852"}}